Literature DB >> 17266014

Avoidable burden of disease: conceptual and methodological issues in substance abuse epidemiology.

Jürgen Rehm1, Benjamin Taylor, Jayadeep Patra, Gerhard Gmel.   

Abstract

Determining the proportion of avoidable disease burden attributable to substance use is important for both policy development and intervention implementation. Current epidemiological theory has in principle provided a method to estimate avoidable burden of disease and the available statistical tools can provide first rough estimates. The method described in this paper, and its statistical procedures, are exemplified to estimate avoidable burden of tobacco-related disease in Canada. However, further effort is needed to find solutions in the methodological details, namely exposure measurement, risk factor multidimensionality, estimation of changes in exposure distribution over time, and estimation of risk relationships from multiple exposures changing over time with multiple endpoints (causal webs). The impetus to begin refining methods to obtain better starting points for estimating avoidable burden of disease is obvious and should be carried through in order to see real changes through evidence-based policy and intervention.

Entities:  

Mesh:

Year:  2006        PMID: 17266014      PMCID: PMC6878591          DOI: 10.1002/mpr.199

Source DB:  PubMed          Journal:  Int J Methods Psychiatr Res        ISSN: 1049-8931            Impact factor:   4.035


  29 in total

1.  On the comparable quantification of health risks: lessons from the Global Burden of Disease Study.

Authors:  C J Murray; A D Lopez
Journal:  Epidemiology       Date:  1999-09       Impact factor: 4.822

2.  Attributable fractions: fundamental concepts and their visualization.

Authors:  G E Eide; I Heuch
Journal:  Stat Methods Med Res       Date:  2001-06       Impact factor: 3.021

3.  Estimating causal effects.

Authors:  George Maldonado; Sander Greenland
Journal:  Int J Epidemiol       Date:  2002-04       Impact factor: 7.196

4.  The world health report 2002 - reducing risks, promoting healthy life.

Authors:  J J Guilbert
Journal:  Educ Health (Abingdon)       Date:  2003-07

5.  The collectivity of drinking cultures: a theory of the distribution of alcohol consumption.

Authors:  O J Skog
Journal:  Br J Addict       Date:  1985-03

6.  Mortality by cause for eight regions of the world: Global Burden of Disease Study.

Authors:  C J Murray; A D Lopez
Journal:  Lancet       Date:  1997-05-03       Impact factor: 79.321

7.  Prevention for multifactorial diseases.

Authors:  S D Walter
Journal:  Am J Epidemiol       Date:  1980-09       Impact factor: 4.897

8.  Regional, disease specific patterns of smoking-attributable mortality in 2000.

Authors:  M Ezzati; A D Lopez
Journal:  Tob Control       Date:  2004-12       Impact factor: 7.552

9.  Changes in depression among abstinent alcoholics.

Authors:  S A Brown; M A Schuckit
Journal:  J Stud Alcohol       Date:  1988-09

10.  Smoking-attributable mortality and expected years of life lost in Canada 2002: conclusions for prevention and policy.

Authors:  Dolly Baliunas; Jayadeep Patra; Jürgen Rehm; Svetlana Popova; Murray Kaiserman; Benjamin Taylor
Journal:  Chronic Dis Can       Date:  2007
View more
  15 in total

1.  Economic benefits of achieving realistic smoking cessation targets in Australia.

Authors:  Anne Magnus; Dominique Cadilhac; Lauren Sheppard; Toby Cumming; Dora Pearce; Rob Carter
Journal:  Am J Public Health       Date:  2010-12-16       Impact factor: 9.308

2.  The economic gains of achieving reduced alcohol consumption targets for Australia.

Authors:  Anne Magnus; Dominique Cadilhac; Lauren Sheppard; Toby Cumming; Dora Pearce; Rob Carter
Journal:  Am J Public Health       Date:  2012-05-17       Impact factor: 9.308

3.  Crude estimates of cannabis-attributable mortality and morbidity in Canada-implications for public health focused intervention priorities.

Authors:  Benedikt Fischer; Sameer Imtiaz; Katherine Rudzinski; Jürgen Rehm
Journal:  J Public Health (Oxf)       Date:  2015-01-28       Impact factor: 2.341

Review 4.  Socioeconomic differences in alcohol-attributable mortality compared with all-cause mortality: a systematic review and meta-analysis.

Authors:  Charlotte Probst; Michael Roerecke; Silke Behrendt; Jürgen Rehm
Journal:  Int J Epidemiol       Date:  2014-03-11       Impact factor: 7.196

5.  Statistical modeling of volume of alcohol exposure for epidemiological studies of population health: the US example.

Authors:  Jürgen Rehm; Tara Kehoe; Gerrit Gmel; Fred Stinson; Bridget Grant; Gerhard Gmel
Journal:  Popul Health Metr       Date:  2010-03-04

6.  Burden of disease associated with alcohol use disorders in the United States.

Authors:  Jürgen Rehm; Deborah Dawson; Ulrich Frick; Gerrit Gmel; Michael Roerecke; Kevin D Shield; Bridget Grant
Journal:  Alcohol Clin Exp Res       Date:  2014-01-15       Impact factor: 3.455

7.  Alcohol-attributable cancer deaths and years of potential life lost in the United States.

Authors:  David E Nelson; Dwayne W Jarman; Jürgen Rehm; Thomas K Greenfield; Grégoire Rey; William C Kerr; Paige Miller; Kevin D Shield; Yu Ye; Timothy S Naimi
Journal:  Am J Public Health       Date:  2013-02-14       Impact factor: 9.308

8.  Population Attributable and Preventable Fractions: Cancer Risk Factor Surveillance, and Cancer Policy Projection.

Authors:  Kevin D Shield; D Maxwell Parkin; David C Whiteman; Jürgen Rehm; Vivian Viallon; Claire Marant Micallef; Paolo Vineis; Lesley Rushton; Freddie Bray; Isabelle Soerjomataram
Journal:  Curr Epidemiol Rep       Date:  2016-08-01

9.  The societal benefits of reducing six behavioural risk factors: an economic modelling study from Australia.

Authors:  Dominique A Cadilhac; Anne Magnus; Lauren Sheppard; Toby B Cumming; Dora C Pearce; Rob Carter
Journal:  BMC Public Health       Date:  2011-06-21       Impact factor: 3.295

10.  Causality and initiation of alcohol control policy. A response to Allamani.

Authors:  Jürgen Rehm; Robin C Purshouse
Journal:  Drug Alcohol Rev       Date:  2021-08-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.